These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36356279)

  • 1. Effects of a Geriatric Assessment Intervention on Patient-Reported Symptomatic Toxicity in Older Adults With Advanced Cancer.
    Culakova E; Mohile SG; Peppone L; Ramsdale E; Mohamed M; Xu H; Wells M; Tylock R; Java J; Loh KP; Magnuson A; Jamieson L; Vogel V; Duberstein PR; Chapman BP; Dale W; Flannery MA
    J Clin Oncol; 2023 Feb; 41(4):835-846. PubMed ID: 36356279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Xu H; Mohamed M; Flannery M; Peppone L; Ramsdale E; Loh KP; Wells M; Jamieson L; Vogel VG; Hall BA; Mustian K; Mohile S; Culakova E
    JAMA Netw Open; 2023 Mar; 6(3):e234198. PubMed ID: 36947036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.
    Presley CJ; Mohamed MR; Culakova E; Flannery M; Vibhakar PH; Hoyd R; Amini A; VanderWalde N; Wong ML; Tsubata Y; Spakowicz DJ; Mohile SG
    Front Oncol; 2022; 12():835582. PubMed ID: 35433441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.
    Mohile SG; Mohamed MR; Xu H; Culakova E; Loh KP; Magnuson A; Flannery MA; Obrecht S; Gilmore N; Ramsdale E; Dunne RF; Wildes T; Plumb S; Patil A; Wells M; Lowenstein L; Janelsins M; Mustian K; Hopkins JO; Berenberg J; Anthony N; Dale W
    Lancet; 2021 Nov; 398(10314):1894-1904. PubMed ID: 34741815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Oncologist-Patient Communication With Functional Status and Physical Performance in Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial.
    Jensen-Battaglia M; Lei L; Xu H; Kehoe L; Patil A; Loh KP; Ramsdale E; Magnuson A; Kleckner AS; Wildes TM; Lin PJ; Mustian KM; Giri G; Whitehead M; Bearden J; Burnette BL; Geer J; Mohile SG; Dunne RF
    JAMA Netw Open; 2022 Mar; 5(3):e223039. PubMed ID: 35302628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.
    Mohile SG; Epstein RM; Hurria A; Heckler CE; Canin B; Culakova E; Duberstein P; Gilmore N; Xu H; Plumb S; Wells M; Lowenstein LM; Flannery MA; Janelsins M; Magnuson A; Loh KP; Kleckner AS; Mustian KM; Hopkins JO; Liu JJ; Geer J; Gorawara-Bhat R; Morrow GR; Dale W
    JAMA Oncol; 2020 Feb; 6(2):196-204. PubMed ID: 31697365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical Trial.
    Li D; Sun CL; Kim H; Soto-Perez-de-Celis E; Chung V; Koczywas M; Fakih M; Chao J; Cabrera Chien L; Charles K; Hughes SFDS; Katheria V; Trent M; Roberts E; Jayani R; Moreno J; Kelly C; Sedrak MS; Dale W
    JAMA Oncol; 2021 Nov; 7(11):e214158. PubMed ID: 34591080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer.
    Kleckner AS; Wells M; Kehoe LA; Gilmore NJ; Xu H; Magnuson A; Dunne RF; Jensen-Battaglia M; Mohamed MR; O'Rourke MA; Vogelzang NJ; Dib EG; Peppone LJ; Mohile SG
    JCO Oncol Pract; 2022 Jan; 18(1):e9-e19. PubMed ID: 34228510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study.
    Magnuson A; Lemelman T; Pandya C; Goodman M; Noel M; Tejani M; Doughtery D; Dale W; Hurria A; Janelsins M; Lin FV; Heckler C; Mohile S
    Support Care Cancer; 2018 Feb; 26(2):605-613. PubMed ID: 28914366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOward a comPrehensive supportive Care intervention for Older men with metastatic Prostate cancer (TOPCOP3): A pilot randomized controlled trial and process evaluation.
    Alibhai SMH; Puts M; Jin R; Godhwani K; Antonio M; Abdallah S; Feng G; Krzyzanowska MK; Soto-Perez-de-Celis E; Papadopoulos E; Mach C; Nasiri F; Sridhar SS; Glicksman R; Moody L; Bender J; Clarke H; Matthew A; McIntosh D; Klass W; Emmenegger U
    J Geriatr Oncol; 2024 Jul; 15(6):101750. PubMed ID: 38521641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.
    Dueck AC; Scher HI; Bennett AV; Mazza GL; Thanarajasingam G; Schwab G; Weitzman AL; Rogak LJ; Basch E
    JAMA Oncol; 2020 Feb; 6(2):e193332. PubMed ID: 31556911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
    Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
    J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Treatment Modification and Treatment Tolerability Among Older Chemotherapy Recipients With Advanced Cancer.
    Mohamed MR; Rich DQ; Seplaki C; Lund JL; Flannery M; Culakova E; Magnuson A; Wells M; Tylock R; Mohile SG
    JAMA Netw Open; 2024 Feb; 7(2):e2356106. PubMed ID: 38358742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists.
    Gilmore N; Xu H; Kehoe L; Kleckner AS; Moorthi K; Lei L; Mohamed MRS; Loh KP; Culakova E; Flannery M; Ramsdale E; Duberstein PR; Canin B; Kamen C; Giri G; Watson E; Patil A; Onitilo AA; Burnette B; Janelsins M; Mohile SG
    Cancer; 2022 Mar; 128(5):1101-1109. PubMed ID: 34762734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.
    da Silva Lopes AM; Colomer-Lahiguera S; Darnac C; Giacomini S; Bugeia S; Gutknecht G; Spurrier-Bernard G; Cuendet M; Muet F; Aedo-Lopez V; Mederos N; Michielin O; Addeo A; Latifyan S; Eicher M
    JMIR Res Protoc; 2023 Oct; 12():e48386. PubMed ID: 37851498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial.
    Oliveira M; Rugo HS; Howell SJ; Dalenc F; Cortes J; Gomez HL; Hu X; Toi M; Jhaveri K; Krivorotko P; Loibl S; Morales Murillo S; Okera M; Nowecki Z; Park YH; Sohn JH; Tokunaga E; Yousef S; Zhukova L; Fulford M; Andrews H; Wadsworth I; D'Cruz C; Turner NC;
    Lancet Oncol; 2024 Sep; 25(9):1231-1244. PubMed ID: 39214106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
    Basch E; Pugh SL; Dueck AC; Mitchell SA; Berk L; Fogh S; Rogak LJ; Gatewood M; Reeve BB; Mendoza TR; O'Mara AM; Denicoff AM; Minasian LM; Bennett AV; Setser A; Schrag D; Roof K; Moore JK; Gergel T; Stephans K; Rimner A; DeNittis A; Bruner DW
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):409-418. PubMed ID: 28463161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review.
    Disalvo D; Moth E; Soo WK; Garcia MV; Blinman P; Steer C; Amgarth-Duff I; Power J; Phillips J; Agar M
    J Geriatr Oncol; 2023 Nov; 14(8):101585. PubMed ID: 37573197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.